Literature DB >> 32124326

Cell-Type Enrichment Analysis of Bulk Transcriptomes Using xCell.

Dvir Aran1.   

Abstract

Tissues are a complex milieu of cell types of different lineages and subtypes, each with its own unique transcriptomic profile. Bulk transcriptome profiling is therefore the sum of the cell-type-specific gene expression weighted by cell-type proportion in the given sample. Deconvolution of gene expression profiles allows to reconstruct the cellular composition of tissues. xCell is a robust computational method that converts gene expression profiles to enrichment scores of 64 immune and stroma cell types across samples. Here, we described the method, discuss correct usage, and demonstrate an analysis of a cohort of peripheral blood mononuclear cells (PBMC).

Keywords:  Cell types; Deconvolution; Gene expression; Gene signatures; Immune cells

Mesh:

Year:  2020        PMID: 32124326     DOI: 10.1007/978-1-0716-0327-7_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  35 in total

1.  Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.

Authors:  Xiangjun Qi; Guoming Chen; Zhuangzhong Chen; Jing Li; Wenmin Chen; Jietao Lin; Lizhu Lin
Journal:  Int J Gen Med       Date:  2021-08-11

2.  Biological functions of RNA modification patterns that define tumor microenvironment and survival outcomes in testicular germ cell tumors.

Authors:  Weijun Tang; Jinke Qian; Shilei Qian
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

3.  Lung metastases share common immune features regardless of primary tumor origin.

Authors:  Sandra García-Mulero; M Henar Alonso; Julián Pardo; Cristina Santos; Xavier Sanjuan; Ramón Salazar; Victor Moreno; Josep María Piulats; Rebeca Sanz-Pamplona
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

4.  Immune determinants of Barrett's progression to esophageal adenocarcinoma.

Authors:  Kiran H Lagisetty; Dyke P McEwen; Derek J Nancarrow; Johnathon G Schiebel; Daysha Ferrer-Torres; Dipankar Ray; Timothy L Frankel; Jules Lin; Andrew C Chang; Laura A Kresty; David G Beer
Journal:  JCI Insight       Date:  2021-01-11

5.  Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.

Authors:  Wenzhong Zheng; Shiqiang Zhang; Huan Guo; Xiaobao Chen; Zhangcheng Huang; Shaoqin Jiang; Mengqiang Li
Journal:  Cell Commun Signal       Date:  2021-03-24       Impact factor: 5.712

6.  Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.

Authors:  Zhengrong Yin; Mei Zhou; Tingting Liao; Juanjuan Xu; Jinshuo Fan; Jingjing Deng; Yang Jin
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

7.  Immune status changing helps diagnose osteoarticular tuberculosis.

Authors:  Tuo Liang; Jiarui Chen; GuoYong Xu; Zide Zhang; Jiang Xue; Haopeng Zeng; Jie Jiang; Tianyou Chen; Zhaojie Qin; Hao Li; Zhen Ye; Yunfeng Nie; Chong Liu; Xinli Zhan
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

8.  Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer.

Authors:  Han Xu; Gangjian Wang; Lili Zhu; Hong Liu; Bingjie Li
Journal:  Aging (Albany NY)       Date:  2020-08-03       Impact factor: 5.682

9.  A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.

Authors:  Jiao-Chen Luan; Teng-Yue Zeng; Qi-Jie Zhang; De-Run Xia; Rong Cong; Liang-Yu Yao; Le-Bin Song; Xiang Zhou; Xuan Zhou; Xiang Chen; Jia-Dong Xia; Ning-Hong Song
Journal:  Cancer Cell Int       Date:  2021-08-06       Impact factor: 5.722

10.  Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.

Authors:  Shan Hua; Zhiwen Xie; Wenhao Wang; Zhong Wan; Min Chen; Sheng Zhao; Juntao Jiang
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.